Induction of osteoprogenitor cell differentiation in rat marrow stroma increases mitochondrial retention of rhodamine 123 in stromal cells
โ Scribed by Benjamin Y. Klein; Irena Gal; Zipora Hartshtark; David Segal
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 706 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
โฆ Synopsis
Bone marrow stromal cells contain colony forming cells with the potential to differentiate inici osteoprogenitor (OPC) cells. OPC-stimulation medium, containing dexamethasone, ascorbate, and p-glycerophosphate is widely used to recruit OPCs in culture. Cultures were incubated 24 h with rhodamine 123 (Rho), on different days, to examine the effect of the OPC-stimulation medium on the mitochondrial membrane potential of stromal cells.
Culturesgrown in both ordinary medium (DMEM with 15% FCS) and OPC-stimulation medium showed 2 Rho retention peaks on days 3-4 and 10-1 1. Between days 5 and 10 there was a drop in Rho retention/cell. OPC-stimulation medium increased Rho retention by at least twice the amount relative to ordinary medium, and has quadrupled it on day 7. Incubation with Rho concentrations above 5.0 kg/ml inhibited the portion of increased Rho retention which W ~S contributed by the OPC-stimulation medium. Prolonged exposure to 0.1, 1 .O, and 10.0 pg/ml Rho for 12 days only slightly increased day 12 ALP activity/cell, had no effect on day-21 mineralization and only the high dose, 10.0 pg/ml, doubled stromal cell proliferation. Under 24 h incubation Rho concentrations of 1 .O bg/ml and below can serve as a marker for mitochondrial membrane potential in differentiating stromal cells. The results indicate that under both culture conditions stromal cell mitochondria undergo cycles of high and low membrane potential states and that the OPC-stimulation medium constantly maintains an elevated membrane potential relative to ordinary medium.
๐ SIMILAR VOLUMES
The purpose of this study was to analyze the ability of sera to reflect the state of bone metabolism by testing the osteogenic response of mesenchymal cells in culture. Sera of 20 peri-and postmenopausal women were tested before the initiation of hormone replacement therapy. The responding cells wer
During bone loss, osteoblast population can be replaced by adipose tissue. This apparent reciprocal relationship between decreased bone density and increased fat formation can be explained by an imbalance in the production of bone-forming and fat-forming cells in the marrow cavity. Thus, osteoblast